Guben Tongluo Formula Protects LPS-induced Damage in Lamina Propria B Lymphocytes Through TLR4/MyD88/NF-κB Pathway

Abstract

Objective

The main pathological feature of immunoglobulin A nephropathy (IgAN), an autoimmune kidney disease, is the deposition of IgA immune complexes, accompanied by mesangial cell proliferation and elevated urine protein. The Guben Tongluo formula (GTF) is a traditional Chinese medicine prescription, which has predominant protective effects on IgAN. However, the therapeutic mechanism of the GTF in IgAN remains elusive. The present study aimed to determine the effects of GTF in treating IgAN via regulating the TLR4/MyD88/NF-κB pathway.

Methods

In the present study, lamina propria B lymphocytes were treated with different concentrations of lipopolysaccharide (LPS) (0, 1, 5, 10 and 20 ng/mL). Flow cytometry was used to define positive CD86⁺CD19⁺ cells. CCK-8 assay was used to examine cell proliferation. RNAi was used to induce TLR4 silencing. qRT-PCR and Western blotting were used to determine gene expression.

Results

It was found that the LPS dose-dependently increased the content of IgA and galactose-deficient IgA1 (Gd-IgA), the levels of TLR4, Cosmc, MyD88 and phosphorylated (p)-NF-κB, and the ratio of CD86⁺CD19⁺ and IgA-producing B cells. However, the TLR4 knockdown reversed the role of LPS. This suggests that TLR4 mediates the effects of LPS on lamina propria B lymphocytes. Furthermore, the GTF could dose-dependently counteract the effects of LPS and TLR4 overexpression on lamina propria B lymphocytes through the TLR4/MyD88/NF-κB pathway.

Conclusion

Collectively, these results demonstrate that the GTF can regulate the TLR4/MyD88/NF-κB pathway to treat IgAN model lamina propria B lymphocytes stimulated by LPS.

Keywords

Guben Tongluo formula / immunoglobulin A nephropathy / lamina propria B lymphocytes / TLR4/MyD88/NF-κB

References

[1] SchenaFP, NistorI. Epidemiology of IgA Nephropathy: A Global Perspective. Semin Nephrol, 2018, 38(5): 435-442

[2] ChenT, LiX, LiY, et al.. Prediction and Risk Stratification of Kidney Outcomes in IgA Nephropathy. Am J Kidney Dis, 2019, 74(3): 300-309

[3] LiaoY, WangZ, WangL, et al.. MicroRNA-27a-3p directly targets FosB to regulate cell proliferation, apoptosis, and inflammation responses in immunoglobulin a nephropathy. Biochem Biophys Res Commun, 2020, 529(4): 1124-1130

[4] CoxSN, SallustioF, SerinoG, et al.. Altered modulation of WNT-beta-catenin and PI3K/Akt pathways in IgA nephropathy. Kidney Int, 2010, 78(4): 396-407

[5] MenonMC, ChuangPY, HeJC. Role of podocyte injury in IgA nephropathy. Contrib Nephrol, 2013, 181: 41-51

[6] MakitaY, SuzukiH, KanoT, et al.. TLR9 activation induces aberrant IgA glycosylation via APRIL- and IL6-mediated pathways in IgA nephropathy. Kidney Int, 2020, 97(2): 340-349

[7] SuzukiH, KirylukK, NovakJ, et al.. The pathophysiology of IgA nephropathy. J Am Soc Nephrol, 2011, 22(10): 1795-1803

[8] PlaczekWJ, YanagawaH, MakitaY, et al.. Serum galactose-deficient-IgA1 and IgG autoantibodies correlate in patients with IgA nephropathy. PLoS One, 2018, 13(1): e0190967

[9] WangM, ChenL, LiuD, et al.. Metabolomics highlights pharmacological bioactivity and biochemical mechanism of traditional Chinese medicine. Chem Biol Interact, 2017, 273: 133-141

[10] TianT, ChenH, ZhaoYY. Traditional uses, phytochemistry, pharmacology, toxicology and quality control of Alisma orientale (Sam.) Juzep: a review. J Ethnopharmacol, 2014, 158: 373-387 Pt A

[11] QingshanMA, GuilingW. Clinical Observation of Curative Effect of Guben Tongluo Formula Granules on Migraine without Aura. Zhongguo Zhongyi Jizheng (Chinese), 2016, 25(6): 1163-1165

[12] JiaminY, YingT, HexinC, et al.. Effects of Guben Tongluo Formula on Expressions of Podocin mRNA and α-actinin-4 mRNA in Rats with IgA Nephropathy Based on Sweat Pore Theory. Shandong Zhongyiyao Daxue Xuebao (Chinese), 2019, 43(3): 301-307

[13] QuanleZ, HongxiaZ, XiaoliGU, et al.. Clinical Studies on Guben Tongluo Therapy of Kidney Collateral Stasis Type of Refractory Nephrotic Syndrome. Zhonghua Zhongyiyao Xuekan (Chinese), 2015, 33(7): 1664-1667

[14] BrandtzaegP. Function of mucosa-associated lymphoid tissue in antibody formation. Immunol Invest, 2010, 39(4–5): 303-355

[15] JianZ, QingW, PeichengS. Effects of Guben Tongluo Formula on NLRP3 in mice with IgA nephropathy. Shanghai Zhongyiyao Zazhi (Chinese), 2020, 54(Suppl1): 183-185

[16] YangM, GanH, ShenQ. Effect of LPS on the level of TLR4 and on the expression of NF-κB and Notch1 in monocytes from patients with type 2 diabetic nephropathy. Zhong Nan Da Xue Xue Bao Yi Xue Ban (Chinese), 2012, 37(6): 578-585

[17] Kasperova A, Ueda H, Stuchlova Horynova M, et al. Inhibition of formation of IgA1-containing immune complexes in IgA1 nephropathy. Front Immunol, 2013, doi: https://doi.org/10.3389/conf.fimmu.2013.02.00287.

[18] TsujiR, IkadoK, FujiwaraD. Modulation of Innate Immunity by lignin-Carbohydrate, a Novel TLR4 Ligand, Results in Augmentation of Mucosal IgA and Systemic IgG Production. Int J Mol Sci, 2017, 26(1): 64 19

[19] ChervonskyAV. Influence of microbial environment on autoimmunity. Nat Immunol, 2010, 11(1): 28-35

[20] ReboldiA, ArnonTI, RoddaLB, et al.. IgA production requires B cell interaction with subepithelial dendritic cells in Peyer’s patches. Science, 2016, 352(6287): aaf4822

[21] HeB, SantamariaR, XuW, et al.. The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88. Nat Immunol, 2010, 11(9): 836-845

[22] McCarthyDD, KujawaJ, WilsonC, et al.. Mice overexpressing BAFF develop a commensal flora-dependent, IgA-associated nephropathy. J Clin Invest, 2011, 121(10): 3991-4002

[23] QinW, ZhongX, FanJM, et al.. External suppression causes the low expression of the Cosmc gene in IgA nephropathy. Nephrol Dial Transplant, 2008, 23(5): 1608-1614

[24] Abbasi-KenarsariH, ShafaghatF, BaradaranB, et al.. Cloning and Expression of CD19, a Human B-Cell Marker in NIH-3T3 Cell Line. Avicenna J Med Biotechnol, 2015, 7(1): 39-44

[25] WangYY, ZhangL, ZhaoPW, et al.. Functional implications of regulatory B cells in human IgA nephropathy. Scand J Immunol, 2014, 79(1): 51-60

[26] SuzukiH, MoldoveanuZ, JulianBA, et al.. Autoantibodies Specific for Galactose-Deficient IgA1 in IgA Vasculitis With Nephritis. Kidney Int Rep, 2019, 4(12): 1717-1724

[27] YamadaK, HuangZQ, RaskaM, et al.. Inhibition of STAT3 Signaling Reduces IgA1 Autoantigen Production in IgA Nephropathy. Kidney Int Rep, 2017, 2(6): 1194-1207

[28] HeZ, DaoliangX, ChanghuaL, et al.. Pathogenesis of IgA nephropathy: abnormal glycosylation of IgA1 and abnormal immunity. Chin J Kidney Dis Invest (Chinese), 2017, 6(4): 182-185

[29] LaiKN. Pathogenesis of IgA nephropathy. Nat Rev Nephrol, 2012, 8(5): 275-283

[30] Feehally J, Allen A. Abnormalities of IgA1 production in IgA nephropathy. Nephrology, 2008,2008. doi.org/https://doi.org/10.1046/j.1440-1797.7.s3.4.x

[31] BurgM, GröneHJ, KochKM, et al.. Cationic dextran induces mesangioproliferative nephritis in rats independent of glomerular IgA deposition. Nephrol Dial Transplant, 1997, 12(9): 1856-1862

[32] WuQ, JindeK, EndohM, et al.. Clinical significance of costimulatory molecules CD80/CD86 expression in IgA nephropathy. Kidney Int, 2004, 65(3): 888-896

[33] WangYY, ZhangL, ZhaoPW, et al.. Functional implications of regulatory B cells in human IgA nephropathy. Scand J Immunol, 2014, 79(1): 51-60

[34] TaylorS, PieriK, NanniP, et al.. Phosphatidylethanolamine binding protein-4 (PEBP4) is increased in IgA nephropathy and is associated with IgA-positive B-cells in affected kidneys. J Autoimmun, 2019, 105: 102309

[35] WuH, ChenG, WyburnKR, et al.. TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest, 2007, 117(10): 2847-2859

[36] ZouJN, XiaoJ, HuSS, et al.. Toll-like Receptor 4 Signaling Pathway in the Protective Effect of Pioglitazone on Experimental Immunoglobulin A Nephropathy. Chin Med J (Engl), 2017, 130(8): 906-913

[37] SanzAB, Sanchez-NiñoMD, RamosAM, et al.. NF-kappaB in renal inflammation. J Am Soc Nephrol, 2010, 21(8): 1254-1262

[38] YamashitaM, YoshidaT, SuzukiS, et al.. Podocyte-specific NF-κB inhibition ameliorates proteinuria in adriamycin-induced nephropathy in mice. Clin Exp Nephrol, 2017, 21(1): 16-26

[39] BaiYJ, DuYB, YuanXZ, et al.. Regulation of Chrysophanol-mediated TLR4/NF-κB Pathway on Renal Injury and Immune Response in IgA Nephropathy Rats. Sichuan Da Xue Xue Bao Yi Xue Ban (Chinese), 2019, 50(6): 840-846

[40] WangF, ZhuM, JiangN, et al.. Paeonol ameliorates lipopolysaccharides-induced acute lung injury by regulating TLR4/MyD88/NF-κB signaling pathway. Pharmazie, 2019, 74(2): 101-106

[41] XuJ, LuC, LiuZ, et al.. Schizandrin B protects LPS-induced sepsis via TLR4/NF-ΰB/MyD88 signaling pathway. Am J Transl Res, 2018, 10(4): 1155-1163

[42] GaoH, LiuX, SunW, et al.. Total tanshinones exhibits anti-inflammatory effects through blocking TLR4 dimerization via the MyD88 pathway. Cell Death Dis, 2017, 8(8): e3004